https://orcid.org/0000-0002-4614-681X
References
- Sastow D, Tatarian J, Riazat-Kesh Y, et al. Multi-institutional analysis of outcomes in acute myeloid leukemia patients with Central nervous system involvement. Leuk Lymphoma. 2023;1–6. doi:10.1080/10428194.2023.2248331
- Frater JL, Shirai CL, Brestoff JR. Technological features of blast identification in the cerebrospinal fluid: A systematic review of flow cytometry and laboratory haematology methods. Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):45–53. doi: 10.1111/ijlh.13869. Epub 2022 Jul 4. PMID: 35785436; PMCID: PMC9463081.
- Szantho E, Karai B, Ivady G, et al. Evaluation of sample quality as preanalytical error in flow cytometry analysis in childhood acute lymphoblastic leukemia. EJIFCC. 2019;30(4):385–395.
- Girard S, Fenneteau O, Mestrallet F, et al. Recommendations for cerebrospinal fluid examination in acute leukemia. Ann Biol Clin (Paris). 2017;75(5):503–512. doi:10.1684/abc.2017.1250
- Wick M, Gross CC, Tumani H, Wildemann B, Stangel M. Clinical neurochemistry DGLN EV: automated analysis of cerebrospinal fluid cells using commercially available blood cell analysis devices-A critical appraisal. Cells 2021, 10(5):1232. doi:10.3390/cells10051232